ACRC/Arizona Clinical Research Center, Inc — Tucson, Arizona

Public research footprint of ACRC/Arizona Clinical Research Center, Inc, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer (NSCLC) · Non-hodgkin Lymphoma · Carcinoma, Transitional Cell · Multiple Myeloma

Recently updated registry entries

NCT04300556 — A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred… (Recruiting)
NCT04504708 — Dose-Escalation and Dose-Expansion Study of ZX-101A in Patients With Relapsed/Resistant… (Terminated)
NCT01239797 — Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat… (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at ACRC/Arizona Clinical Research Center, Inc?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.